VYNE Therapeutics Inc - fluxo de caixa trimestral (NASDAQ:VYNE) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Total assets 66.91 M56.42 M44.72 M30.16 M Total liabilities 14.82 M12.29 M5.84 M2.4 M Total equity 52.09 M44.13 M38.88 M27.77 M Total liabilities & shareholders' equities 66.91 M56.42 M44.72 M30.16 M Total debt 99 K63 K25 K0 Net debt -61.42 M-50.21 M-39.62 M-29.01 M

Notícias

VYNE Therapeutics se fundirá com Yarrow Bioscience em acordo de US$ 200 milhões

VYNE Therapeutics to merge with Yarrow Bioscience in $200 million deal

VYNE Therapeutics Inc. (VYNE) Yarrow Bioscience, Inc. - M&A Call Prepared Remarks Transcript

Ações da Vyne Therapeutics disparam após fusão com a Yarrow Bioscience

Vyne Therapeutics stock soars after merger with Yarrow Bioscience

VYNE and Yarrow Bioscience to merge in all-stock transaction

Crude Oil Rises Over 1%; General Mills Earnings Top Views - DBV Technologies (NASDAQ:DBVT), General Mills (NYSE:GIS)

Dow Jumps 150 Points; Jabil Posts Upbeat Earnings - Aditxt (NASDAQ:ADTX), Agape ATP (NASDAQ:ATPC)

VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates

VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates

Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates

Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates